Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Arthritis Rheum (2007) 56(9):297585
Comparative Efficacy of Incretin-Based Therapies After ~48 Weeks This bar chart presents a direct comparison between Mazdutide 6 mg, Tirzepatide 15 mg, Semaglutide 2.4 mg, and Placebo across three key anthropometric outcomes: Percentage Weight Loss Tirzepatide: 15.0% Mazdutide: 14.0% Semaglutide: 12.4% Placebo: +0.3% Patients Achieving 15% Weight Loss Tirzepatide: 51.0% Mazdutide: 49.5% Semaglutide: 36.0% Placebo: 2.0% Reduction in Waist Circumference (cm) Mazdutide: 10.7 cm Tirzepatide: 9.5 cm Semaglutide: 8.5 cm Placebo: 1.4 cm Interpretation Mazdutide demonstrates comparable efficacy to tirzepatide in both absolute weight reduction and waist circumference improvement, outperforming semaglutide across these endpoints
If peptide therapy is appropriate, well outline options and next steps
In the body, these small chains of amino acids function as signaling molecules that may promote bone formation, reduce inflammation, and accelerate healing
US$ 26.24
US$ 27.82
US$ 21.06
US$ 25.28
US$ 20.16
US$ 25.54
US$ 24.19
